PointState Capital’s Celgene Corp CELG Stock Holding History

PointState Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,553,059	Closed	-$147M	–	170
2019 Q1	$147M	Buy	+1,553,059	New	+$136M	2.89%	9
2017 Q2	–	Sell	-213,100	Closed	-$26.5M	–	193
2017 Q1	$26.5M	Sell	213,100 -459,700	-68%	-$55M	0.28%	65
2016 Q4	$77.9M	Sell	672,800 -358,700	-35%	-$39.9M	1.12%	26
2016 Q3	$108M	Sell	1,031,500 -1,144,500	-53%	-$124M	1.11%	24
2016 Q2	$215M	Buy	2,176,000 +591,500	+37%	+$61.2M	4.42%	5
2016 Q1	$159M	Buy	+1,584,500	New	+$163M	4.27%	7
2015 Q1	–	Sell	-150,000	Closed	-$16.8M	–	170
2014 Q4	$16.8M	Buy	+150,000	New	+$15.8M	0.29%	66

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

PointState Capital's CELG Position: Q2 2019 in Review

PointState Capital sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 1,553,059 shares — an estimated $147M sold.

PointState Capital first reported a position in CELG in Q4 2014 and held it in 7 quarters. The position peaked at $215M in Q2 2016. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

PointState Capital reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
PointState Capital sold 1,553,059 Celgene Corp shares in Q2 2019, an estimated $147M.
PointState Capital first reported a position in Celgene Corp in Q4 2014 and held it in 7 quarters.
PointState Capital's Celgene Corp position peaked at $215M in Q2 2016.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on PointState Capital's 13F filing for Q2 2019, filed 14 Aug 2019.